PACB
Companies
NASDAQ
Pacific Biosciences of California, Inc.
Health Care
$1.31
-$0.52 (-28.42%)
Price Chart
Overview
About PACB
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
Market Cap
$547.4M
Volume
11.9M
Avg. Volume
10.4M
P/E Ratio
-1.5
Dividend Yield
0.00%
Employees
747.0
Company Information
Risk & Correlation Analysis
Market Correlation
3.05
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PACB shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$547.4M
Volume11.9M
P/E Ratio-1.50
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 11, 2026Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025